+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Topical duodenal and gastric mucosal production of interleukin-1 beta, interleukin-6, interleukin-8, tumor necrosis factor alfa and interleukin-2-soluble receptor in Helicobacter pylori positive and negative patients A pilot study



Topical duodenal and gastric mucosal production of interleukin-1 beta, interleukin-6, interleukin-8, tumor necrosis factor alfa and interleukin-2-soluble receptor in Helicobacter pylori positive and negative patients A pilot study



Gut 39(Suppl. 2): A39-A40




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034018902

Download citation: RISBibTeXText


Related references

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 29(5): 425-429, 1994

Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 99(3): 276-284, 2005

Mucosal Tumor Necrosis Factor-or, Interleukin-1/3, and Interleukin-8 Production in Patients with Helicobacter pylori Infection. Scandinavian Journal of Gastroenterology 29(5): 425-429, 1994

Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. International Journal of Clinical and Laboratory Research 26(3): 207-210, 1996

Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis rapid induction of tumor necrosis factor alpha interleukin 1 beta interleukin 6 gamma interferon and soluble interleukin 2 receptor m r 55000 protein. Cancer Research 52(5): 1123-1128, 1992

Plasma Concentrations of Interleukin-1β, Interleukin-6, Soluble Interleukin-2 Receptor and Tumor Necrosis Factor α of Depressed Patients in Japan. Neuropsychobiology 43(2): 59-62, 2001

Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2. International Journal of Clinical & Laboratory Research 26(3): 207-210, 1996

Mechanism of interleukin-8 production in gastric epithelial cells stimulated by Helicobacter pylori, interleukin-1 and tumor necrosis factor-alpha. Gastroenterology 110(4 Suppl. ): A62, 1996

Cytokines and malaria. Study of tumour necrosis factor alpha, interleukin 1 beta, interleukin 6 and of the soluble interleukin 2 receptor in 28 patients. Bulletin de la Societe de Pathologie Exotique 87(2): 91-96, 1994

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 43(2): 59-62, 2001

Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Digestive Diseases and Sciences 39(7): 1525-1531, 1994

Elevated levels of tumor necrosis factor interleukin 1 beta and soluble interleukin 2 receptor in plasma from patients with disseminated intravascular coagulation. Mie Medical Journal 40(2): 283-288, 1990

Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. American Journal of Rhinology 14(6): 367-373, 2001

Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson's disease. Cellular Immunology 327: 77-82, 2018

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Disease and Associated Disorders 12(3): 215-227, 1998